CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.85B, above the global median of $1.18B
- FinancialsAltman Z-Score 4.52: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.06%Below 5Y avg (2.09%)
Annual Rate
CNY 0.24Paid annual
Payout Ratio
90.9%High
Payback Period
93.9 yr
Last Ex-Dividend
Apr 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
25.94BCNY3.85B · vs all stocks (USD)
Trailing P/E
28.46xRevenue (TTM)
9.50BCNY1.41B · vs all stocks (USD)
Profit Margin
9.38%Beta
0.2140xvs all stocks
52-Week Change
37.11%vs all stocks
Market Capitalization
25.94BCNY3.85B · vs all stocks (USD)
Enterprise Value
22.92BCNY3.40B · vs all stocks (USD)
Trailing P/E
28.46xForward P/E
21.55xPEG Ratio
23.27xPrice to Sales (TTM)
2.71xPrice to Book (MRQ)
3.81xEnterprise to Revenue
2.41xEnterprise to EBITDA
14.04xGross Margin
29.30%Profit Margin
9.38%Operating Margin
13.76%Return on Assets (TTM)
4.74%Return on Equity (TTM)
13.14%Revenue (TTM)
9.50BCNY1.41B · vs all stocks (USD)
Revenue per Share (TTM)
8.26CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-10.40%Gross Profit (TTM)
2.55BCNY377.81M · vs all stocks (USD)
EBITDA (TTM)
1.20BCNY177.38M · vs all stocks (USD)
Net Income (TTM)
891.15MCNY132.16M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
0.20%Operating Cash Flow (TTM)
1.36BCNY201.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
592.48MCNY87.86M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2380CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
1.06%vs all stocks
5-Year Average Dividend Yield
2.09%vs all stocks
Payout Ratio
90.90%Minority Interest (Equity)
7.92MCNYFY2025 · Dec 31, 2025Revenue
9.78BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
7.20BCNYFY2025 · Dec 31, 2025Gross Profit
2.58BCNYFY2025 · Dec 31, 2025Operating Income
1.07BCNY158.20M · vs all stocks (USD)
Pre-tax Income
1.07BCNYFY2025 · Dec 31, 2025Income Tax Expense
175.52MCNYFY2025 · Dec 31, 2025Net Income
890.68MCNYFY2025 · Dec 31, 2025EBIT
1.09BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.84BCNYFY2025 · Dec 31, 2025Research & Development
611.17MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
550.46MCNYFY2025 · Dec 31, 2025Other Operating Expenses
60.29MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
112.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
24.65MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7723CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7723CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
890.68MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-3.70KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
847.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
494.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.92BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
890.68MCNYFY2025 · Dec 31, 2025Other Non-cash Items
43.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-227.87MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
141.26MCNYFY2025 · Dec 31, 2025Capital Expenditures
-353.19MCNYFY2025 · Dec 31, 2025Net Acquisitions
30.18MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.30BCNYFY2025 · Dec 31, 2025Sale of Investments
1.25BCNYFY2025 · Dec 31, 2025Other Investing Activity
-161.34KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-372.32MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.13BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.42BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-836.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
-525.88MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-643.09MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.16BSharesUpdated Aug 18, 2026Float Shares
489.74MSharesUpdated Aug 18, 2026% Held by Insiders
54.92%vs all stocks
% Held by Institutions
9.28%vs all stocks
Total Cash (MRQ)
3.63BCNY539.01M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.23CNYUpdated Aug 18, 2026Total Debt (MRQ)
1.56BCNY230.61M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2367xCurrent Ratio (MRQ)
1.55xBook Value per Share (MRQ)
5.83CNYUpdated Aug 18, 2026Total Assets
12.32BCNY1.83B · vs all stocks (USD)
Total Current Assets
7.88BCNYFY2025 · Dec 31, 2025Total Liabilities
5.97BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.44BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
606.76MCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.37BCNYFY2025 · Dec 31, 2025Cash
2.92BCNYFY2025 · Dec 31, 2025Cash Equivalents
864.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.79BCNYFY2025 · Dec 31, 2025Accounts Receivable
1.71BCNYFY2025 · Dec 31, 2025Inventory
1.60BCNYFY2025 · Dec 31, 2025Accounts Payable
3.38BCNYFY2025 · Dec 31, 2025Short-term Debt
1.07BCNYFY2025 · Dec 31, 2025Other Current Liabilities
246.87MCNYFY2025 · Dec 31, 2025Long-term Debt
487.21MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.16BCNYFY2025 · Dec 31, 2025Retained Earnings
5.11BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.35BCNY941.16M · vs all stocks (USD)
Treasury Stock
482.06MCNYFY2025 · Dec 31, 202552-Week Low
14.89CNYUpdated Aug 18, 202652-Week High
24.85CNYUpdated Aug 18, 202652-Week Change
37.11%vs all stocks
Beta
0.2140xvs all stocks
50-Day MA
18.84CNYUpdated Aug 18, 2026200-Day MA
17.68CNYUpdated Aug 18, 2026Avg 10-Day Volume
38.35MSharesUpdated Aug 18, 2026Avg 30-Day Volume
27.40MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
0.7800CNYUpdated Aug 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.52: safe zoneNotable
Altman Z-Score: 4.52
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.85B, above the global median of $1.18BNotable
Market cap (USD): 3,846,538,912.068Global Median: 1,179,398,897.704
Revenue is $1.41B, above the global median of $534.05MNotable
Revenue (USD): 1,408,971,980.902Global Median: 534,052,387.958
Levered free cash flow is $87.86M, above the global median of $19.19MNotable
Levered free cash flow (USD): 87,864,765.018Global Median: 19,189,974.917
Companies that share the same coordination system — how they create, deliver, or capture value.
Arcus Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Catalyst Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Irhythm Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Zhejiang Huahai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Duality Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Xiamen Amoytop Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Livzon Pharmaceutical Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Denali Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Viking Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule